{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:08:27Z","timestamp":1785499707527,"version":"3.56.0"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.15333","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T15:33:45Z","timestamp":1654270425000},"page":"e2215333","source":"Crossref","is-referenced-by-count":7,"title":["Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit\/Hyperactivity Disorder in Offspring"],"prefix":"10.1001","volume":"5","author":[{"given":"Gerd Marie","family":"Harris","sequence":"first","affiliation":[{"name":"Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie","family":"Wood","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway"},{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Ystrom","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway"},{"name":"Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"PROMENTA Research Center, Department of Psychology, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Nordeng","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway"},{"name":"Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"zoi220448r1","doi-asserted-by":"publisher","year":"2018","journal-title":"Cephalalgia","DOI":"10.1177\/0333102417738202"},{"issue":"11","key":"zoi220448r2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"17","author":"GBD 2016 Headache Collaborators","year":"2018","journal-title":"Lancet Neurol"},{"issue":"12","key":"zoi220448r3","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/j.1468-2982.2009.01869.x","article-title":"Maternal characteristics and migraine pharmacotherapy during pregnancy: cross-sectional analysis of data from a large cohort study.","volume":"29","author":"Nezvalov\u00e1-Henriksen","year":"2009","journal-title":"Cephalalgia"},{"issue":"12","key":"zoi220448r4","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00228-016-2127-9","article-title":"Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women.","volume":"72","author":"Amundsen","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"zoi220448r5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/pds.3902","article-title":"Prenatal triptan exposure and parent-reported early childhood neurodevelopmental outcomes: an application of propensity score calibration to adjust for unmeasured confounding by migraine severity.","volume":"25","author":"Wood","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"zoi220448r6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256214","article-title":"Perinatal use of triptans and other drugs for migraine\u2014a nationwide drug utilization study.","volume":"16","author":"Tauqeer","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"zoi220448r7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12884-017-1399-0","article-title":"Patterns and predictors of analgesic use in pregnancy: a longitudinal drug utilization study with special focus on women with migraine.","volume":"17","author":"Harris","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"zoi220448r8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrneurol.2015.29","article-title":"Pharmacological treatment of migraine during pregnancy and breastfeeding.","volume":"11","author":"Amundsen","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"zoi220448r9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/head.2019.59.issue-6","article-title":"Pregnancy, birth, neonatal, and postnatal neurological outcomes after pregnancy with migraine.","volume":"59","author":"Skajaa","year":"2019","journal-title":"Headache"},{"issue":"4","key":"zoi220448r10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/head.2015.55.issue-4","article-title":"Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.","volume":"55","author":"Marchenko","year":"2015","journal-title":"Headache"},{"issue":"2","key":"zoi220448r11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/ppe.12253","article-title":"Prenatal triptan exposure and internalising and externalising behaviour problems in 3-year-old children: results from the Norwegian Mother and Child Cohort Study.","volume":"30","author":"Wood","year":"2016","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"9","key":"zoi220448r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011971","article-title":"Longitudinal changes in neurodevelopmental outcomes between 18 and 36 months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study.","volume":"6","author":"Wood","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"zoi220448r13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ppe.2018.32.issue-3","article-title":"Prenatal triptan exposure and neurodevelopmental outcomes in 5-year-old children: follow-up from the Norwegian Mother and Child Cohort Study.","volume":"32","author":"Harris","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"6","key":"zoi220448r14","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis.","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"7","key":"zoi220448r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219778","article-title":"Use and validity of child neurodevelopment outcome measures in studies on prenatal exposure to psychotropic and analgesic medications\u2014a systematic review.","volume":"14","author":"Hjorth","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"zoi220448r16","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/ije\/dyl170","article-title":"Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).","volume":"35","author":"Magnus","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"2","key":"zoi220448r17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/ije\/dyw029","article-title":"Cohort profile update: the Norwegian Mother and Child Cohort Study (MoBa).","volume":"45","author":"Magnus","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"26","key":"zoi220448r19","first-page":"2546","article-title":"Medical birth registry\u2014an essential resource in perinatal medical research.","volume":"122","author":"Irgens","year":"2002","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"1","key":"zoi220448r20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4045\/tidsskr.13.1417","article-title":"The Norwegian patient register\u2014an important source for research.","volume":"134","author":"Bakken","year":"2014","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"2","key":"zoi220448r22","doi-asserted-by":"publisher","DOI":"10.5324\/nje.v18i2.23","article-title":"Establishment of the nationwide Norwegian Prescription Database (NorPD)\u2014new opportunities for research in pharmacoepidemiology in Norway.","volume":"18","author":"Furu","year":"2009","journal-title":"Norsk Epidemiologi"},{"issue":"4","key":"zoi220448r24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/ppe.2017.31.issue-4","article-title":"Antidepressant use in pregnancy and the risk of attention deficit with or without hyperactivity disorder in children.","volume":"31","author":"Boukhris","year":"2017","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"9","key":"zoi220448r25","doi-asserted-by":"publisher","first-page":"e003507","DOI":"10.1136\/bmjopen-2013-003507","article-title":"In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study.","volume":"3","author":"Laugesen","year":"2013","journal-title":"BMJ Open"},{"key":"zoi220448r26","doi-asserted-by":"publisher","first-page":"j2350","DOI":"10.1136\/bmj.j2350","article-title":"Prenatal antidepressant use and risk of attention-deficit\/hyperactivity disorder in offspring: population based cohort study.","volume":"357","author":"Man","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"zoi220448r27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1023\/A:1022602400621","article-title":"The revised Conners\u2019 Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity.","volume":"26","author":"Conners","year":"1998","journal-title":"J Abnorm Child Psychol"},{"issue":"3","key":"zoi220448r28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1207\/S15327752JPA8003_04","article-title":"Factorial validity of the Conners\u2019 Parent Rating Scale\u2013revised: short form with psychiatric outpatients.","volume":"80","author":"Kumar","year":"2003","journal-title":"J Pers Assess"},{"issue":"12","key":"zoi220448r29","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1177\/1087054717696765","article-title":"Early predictors of ADHD: evidence from a prospective birth cohort.","volume":"24","author":"Oerbeck","year":"2020","journal-title":"J Atten Disord"},{"issue":"2","key":"zoi220448r30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/08039480310000932","article-title":"Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36).","volume":"57","author":"Strand","year":"2003","journal-title":"Nord J Psychiatry"},{"issue":"1","key":"zoi220448r31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1207\/s15327752jpa4901_13","article-title":"The Satisfaction With Life Scale.","volume":"49","author":"Diener","year":"1985","journal-title":"J Pers Assess"},{"issue":"10100","key":"zoi220448r32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"390","author":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"zoi220448r33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0333102415580099","article-title":"Quality of life in primary headache disorders: a review.","volume":"36","author":"Abu Bakar","year":"2016","journal-title":"Cephalalgia"},{"issue":"4","key":"zoi220448r34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/sjop.12056","article-title":"Social problem-solving, perceived stress, depression and life-satisfaction in patients suffering from tension type and migraine headaches.","volume":"54","author":"Eskin","year":"2013","journal-title":"Scand J Psychol"},{"issue":"3","key":"zoi220448r35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"12","key":"zoi220448r36","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models.","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"6","key":"zoi220448r37","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/joim.12197","article-title":"Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs.","volume":"275","author":"St\u00fcrmer","year":"2014","journal-title":"J Intern Med"},{"issue":"5","key":"zoi220448r38","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology.","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"4","key":"zoi220448r39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.v30.4","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"2","key":"zoi220448r41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S0033291704002892","article-title":"The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population.","volume":"35","author":"Kessler","year":"2005","journal-title":"Psychol Med"},{"issue":"6","key":"zoi220448r42","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/ije\/dyu149","article-title":"Good practices for quantitative bias analysis.","volume":"43","author":"Lash","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"1-4","key":"zoi220448r43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/153450849902401-409","article-title":"Conners\u2019 Rating Scales\u2013Revised (CRS-R).","volume":"24","author":"Mueller","year":"1999","journal-title":"Diagnostique"},{"issue":"20","key":"zoi220448r44","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.4045\/tidsskr.18.0418","article-title":"Diagnostikk av hyperkinetisk forstyrrelse hos barn i Norge.","volume":"138","author":"Sur\u00e9n","year":"2018","journal-title":"Tidsskr Nor Legeforen"},{"issue":"12","key":"zoi220448r45","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamapsychiatry.2018.2728","article-title":"Association of autism spectrum disorder with prenatal exposure to medication affecting neurotransmitter systems.","volume":"75","author":"Janecka","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"zoi220448r47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1472-6874-13-50","article-title":"Agreement of self-reported physician diagnosis of migraine with International Classification of Headache Disorders-II migraine diagnostic criteria in a cross-sectional study of pregnant women.","volume":"13","author":"Qiu","year":"2013","journal-title":"BMC Womens Health"},{"key":"zoi220448r48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eurpsy.2016.01.2427","article-title":"The validity and reliability of the diagnosis of hyperkinetic disorders in the Danish Psychiatric Central Research Registry.","volume":"35","author":"Mohr-Jensen","year":"2016","journal-title":"Eur Psychiatry"},{"issue":"6","key":"zoi220448r49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/ppe.2009.23.issue-6","article-title":"Self-selection and bias in a large prospective pregnancy cohort in Norway.","volume":"23","author":"Nilsen","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"10","key":"zoi220448r50","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10654-019-00550-1","article-title":"Bias from self selection and loss to follow-up in prospective cohort studies.","volume":"34","author":"Biele","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"zoi220448r51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00787-017-1045-4","article-title":"ADHD is associated with migraine: a systematic review and meta-analysis.","volume":"27","author":"Salem","year":"2018","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"7","key":"zoi220448r52","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1177\/1087054717710767","article-title":"ADHD is comorbid to migraine in childhood: a population-based study.","volume":"24","author":"Arruda","year":"2020","journal-title":"J Atten Disord"},{"issue":"9","key":"zoi220448r53","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S2215-0366(21)00171-1","article-title":"Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study.","volume":"8","author":"Du Rietz","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"zoi220448r40","author":"StataCorp","year":"2019"},{"key":"zoi220448r18","unstructured":"Norwegian Institute of Public Health. Questionnaires from MoBa. Published 2005. Updated 2021. Accessed January 10, 2022. https:\/\/www.fhi.no\/en\/studies\/moba\/for-forskere-artikler\/questionnaires-from-moba\/"},{"key":"zoi220448r21","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems: 10th revision (ICD-10)\u2014WHO version for 2016. Accessed November 14, 2019. https:\/\/icd.who.int\/browse10\/2016\/en#\/XX"},{"key":"zoi220448r23","unstructured":"WHO Collaborating Centre for Drugs Statistics Methodology. ATC\/DDD index 2022. Published 2021. Accessed November 14, 2021. https:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"zoi220448r46","unstructured":"OECD Better Life Index. Norway. Accessed January 10, 2022. https:\/\/www.oecdbetterlifeindex.org\/countries\/norway\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2792960\/harris_2022_oi_220448_1653581797.29695.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T15:33:50Z","timestamp":1654270430000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2792960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.15333","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]}}}